Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 1/20 | 0.71 |
| ▸ | TUBB | P07437 | 1/20 | 0.71 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.71 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.71 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.71 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.71 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.71 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.71 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.71 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.71 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.71 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.71 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.71 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.71 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.71 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3166384 | 0.92 | TUBB4A (0.85) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28516015 | 0.92 | TUBB4A (0.65) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28511887 | 0.92 | TUBB4A (0.65) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28510684 | 0.92 | TUBB4A (0.65) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL3854264 | 0.89 | TUBB4A (0.67) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28510661 | 0.89 | TUBB4A (0.61) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL3851419 | 0.88 | TUBB4A (0.69) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28520391 | 0.87 | TUBB4A (0.62) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL14524533 | 0.85 | ADORA1 (0.69) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28512721 | 0.85 | ADORA1 (0.69) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230145174-A1 | Systems and Methods Related to Electrical Stimulation of Mammalian Meridians | NINURTA INC (US) | 2023-05-11 | — | — | US | claimed |
| CN-108883191-B | Antibody-conjugates with improved therapeutic index for targeting CD30 tumors and methods for improving the therapeutic index of antibody-conjugates | 西纳福克斯股份有限公司 | 2022-10-14 | — | — | CN | claimed |
| EP-4615309-A1 | METHODS AND APPARATUS FOR ELECTRO-MERIDIAN DIAGNOSTICS | Ninurta Inc. (US) | 2025-09-17 | — | — | EP | disclosed |
| CN-115279730-B | 2, 5-Or 2, 6-disubstituted hydroquinone derivatives having at least one carboxyl, sulfo or amido group, useful as medicaments | OM药物公司 | 2025-02-14 | — | — | CN | disclosed |
| EP-4118069-B1 | PARA-HYDROQUINONE DERIVATIVES AS VEGF, TNF AND/OR IL INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATORY DISEASES | OM PHARMA SA (CH) | 2024-10-23 | — | — | EP | disclosed |
| CN-114656573-B | Deimmunized shiga toxin a subunit scaffolds and cell targeting molecules comprising the same | 分子模板公司 | 2024-09-27 | — | — | CN | disclosed |
| US-12070444-B2 | Modulation of molecular markers using S-equol | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-08-27 | — | — | US | disclosed |
| CN-114436955-B | Tetrahydroquinoline and benzomorpholine derivatives or salts thereof, and preparation method and application thereof | 复旦大学 | 2024-08-09 | — | — | CN | disclosed |
| WO-2024155338-A1 | METHODS AND APPARATUS FOR ELECTRO-MERIDIAN DIAGNOSTICS | NINURTA INC. (US) | 2024-07-25 | — | — | WO | disclosed |
| EP-4251281-A1 | MODULATION OF MOLECULAR MARKERS USING S-EQUOL | Li, Rong (US) | 2023-10-04 | — | — | EP | disclosed |
| US-20230293882-A1 | APPARATUS AND METHOD FOR TREATMENT OF NOCTURNAL ENURESIS | HOWE ADAM SHATTUCK (US) | 2023-09-21 | — | — | US | disclosed |
| US-20220281926-A1 | DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS AND CELL-TARGETING MOLECULES COMPRISING THE SAME | ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE | 2022-09-08 | — | — | US | disclosed |
| WO-2022115582-A9 | MODULATION OF MOLECULAR MARKERS USING S-EQUOL | LI RONG (US) | 2022-08-18 | — | — | WO | disclosed |
| CN-114656573-A | Deimmunized shiga toxin a subunit scaffolds and cell targeting molecules comprising them | 分子模板公司 | 2022-06-24 | — | — | CN | disclosed |
| US-11365223-B2 | De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same | MOLECULAR TEMPLATES, INC. (US) | 2022-06-21 | — | — | US | disclosed |
| WO-2022115582-A1 | MODULATION OF MOLECULAR MARKERS USING S-EQUOL | LI RONG (US) | 2022-06-02 | — | — | WO | disclosed |
| CN-114565896-A | Cross-layer fusion improved YOLOv4 road target recognition algorithm | 西安电子科技大学 | 2022-05-31 | — | — | CN | disclosed |
| US-20220160678-A1 | MODULATION OF MOLECULAR MARKERS USING S-EQUOL | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-05-26 | — | — | US | disclosed |
| CN-107849096-B | Deimmunized shiga toxin a subunit scaffolds and cell targeting molecules comprising them | 分子模板公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-114436955-A | Tetrahydroquinoline and benzomorpholine derivatives or salts thereof, and preparation method and application thereof | 复旦大学 | 2022-05-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160678-A1 | MODULATION OF MOLECULAR MARKERS USING S-EQUOL | BRCA1, ESRRG, ESR1 | TUBB4A 1913/4885TUBB 1574/4885TUBA3C 2565/4885 |
| US-12070444-B2 | Modulation of molecular markers using S-equol | BRCA1, ESRRG, ESR1 | TUBB4A 1913/4885TUBB 1574/4885TUBA3C 2565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.